Physician profile
John L Frattarelli
NPI 1356323091
$15,912.81
in general payments reported to CMS, 2019-2025
16 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 93% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,870 · 2021: $476 · 2022: $582 · 2023: $358 · 2024: $210 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171 · Travel and Lodging: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.43 |
| Travel and Lodging | $1,053.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $12,666.05 | 2019-2025 | Menopur |
| Granata Bio Corporation | $1,413.39 | 2025 | |
| Emd Serono, INC. | $572.32 | 2019-2025 | |
| Vitrolife INC. | $263.71 | 2022 | |
| Coopersurgical, INC. | $257.59 | 2021-2024 | Stripper |
| Organon LLC | $139.44 | 2021-2025 | Nexplanon, Follistim Aq, Ganirelix Acetate |
| Ferring Pharmaceuticals As | $126.88 | 2022 | |
| Covidien LP | $120.48 | 2019 | |
| Hologic Sales and Service, LLC | $117.61 | 2021 | |
| Merck Sharp & Dohme LLC | $106.44 | 2019-2020 | |
| Amgen INC. | $42.37 | 2019 | |
| Myriad Genetic Laboratories, INC. | $36.36 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $22.16 | 2024 | Imfinzi |
| Sumitomo Pharma America, INC. | $15.34 | 2023 | Myfembree |
| Abbvie INC. | $12.67 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Frattarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.